Parsippany-based Watson Pharmaceuticals Inc. last week launched its authorized generic version of Concerta, Johnson & Johnson’s blockbuster attention deficit hyperactive disorder treatment. The launch ...

OMAHA, Neb. (WOWT) - Attention-deficit/hyperactivity disorder (ADHD) impacts millions of kids and adults. At Children’s Omaha, Psychiatry Division Chief Dr ...

Many of the ADHD medication shortages that have plagued the U.S. for the last two years have now been resolved, the Food and Drug Administration says. Yet some doctors and patients report they are ...

An internal US Food and Drug Administration (FDA) re-examination of previously submitted data has raised concerns that two generic medications used to treat attention ...

Sept 14 (Reuters) - Impax Laboratories Inc and Israel's Teva Pharmaceutical Industries Ltd settled a two-year patent dispute with Johnson & Johnson, allowing the generic drugmakers to start selling a ...

A U.S. shortage of the new generic version of Vyvanse, an ADHD medication, is due in part to federal limits on production, according to an industry group representing generic drug makers.

WASHINGTON — The Drug Enforcement Administration has increased the production limit for the ADHD drug Vyvanse and its generic versions to combat the medicine's ongoing shortage, according to a notice ...

For the roughly 10 million adults and six million children in the U.S. diagnosed with ADHD, getting a prescription filled with the exact medication ordered by a physician is a challenge. The FDA first ...